Hart S - Search Results

1

Harrison PT, Hart S. Harrison PT, et al. Among authors: hart s. Exp Physiol. 2018 Apr 1;103(4):439-448. doi: 10.1113/EP086047. Epub 2018 Jan 25. Exp Physiol. 2018. PMID: 29282799 Free article. Review.

2

Genetic therapies for cystic fibrosis lung disease.

Hart SL, Harrison PT. Hart SL, et al. Curr Opin Pharmacol. 2017 Jun;34:119-124. doi: 10.1016/j.coph.2017.10.006. Epub 2017 Nov 5. Curr Opin Pharmacol. 2017. PMID: 29107808 Review.

3

Gene editing and gene regulation with CRISPR.

Harrison P, Hart S. Harrison P, et al. Among authors: hart s. Exp Physiol. 2018 Apr 1;103(4):437-438. doi: 10.1113/EP086864. Exp Physiol. 2018. PMID: 29603460 Free article. No abstract available.

4

Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing.

Walker AJ, Graham C, Greenwood M, Woodall M, Maeshima R, O'Hara-Wright M, Sanz DJ, Guerrini I, Aldossary AM, O'Callaghan C, Baines DL, Harrison PT, Hart SL. Walker AJ, et al. Mol Ther Methods Clin Dev. 2023 Oct 18;31:101140. doi: 10.1016/j.omtm.2023.101140. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 38027060 Free PMC article.

5

CRISPR/Cas9 gene editing therapies for cystic fibrosis.

Graham C, Hart S. Graham C, et al. Among authors: hart s. Expert Opin Biol Ther. 2021 Jun;21(6):767-780. doi: 10.1080/14712598.2021.1869208. Epub 2021 Feb 2. Expert Opin Biol Ther. 2021. PMID: 33412935

6

Topical gene editing therapeutics using lipid nanoparticles: 'gene creams' for genetic skin diseases?

Guri-Lamce I, AlRokh Y, Kim Y, Maeshima R, Graham C, Hart SL, McGrath JA, Jacków-Malinowska J. Guri-Lamce I, et al. Br J Dermatol. 2024 Apr 17;190(5):617-627. doi: 10.1093/bjd/ljad528. Br J Dermatol. 2024. PMID: 38149939 Review.

7

Multifunctional nanocomplexes for gene transfer and gene therapy.

Hart SL. Hart SL. Cell Biol Toxicol. 2010 Feb;26(1):69-81. doi: 10.1007/s10565-009-9141-y. Epub 2010 Feb 3. Cell Biol Toxicol. 2010. PMID: 20127400 Review.

8

Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers.

Grosse SM, Tagalakis AD, Mustapa MF, Elbs M, Meng QH, Mohammadi A, Tabor AB, Hailes HC, Hart SL. Grosse SM, et al. FASEB J. 2010 Jul;24(7):2301-13. doi: 10.1096/fj.09-144220. Epub 2010 Mar 4. FASEB J. 2010. PMID: 20203088

9

BMI-1 extends proliferative potential of human bronchial epithelial cells while retaining their mucociliary differentiation capacity.

Munye MM, Shoemark A, Hirst RA, Delhove JM, Sharp TV, McKay TR, O'Callaghan C, Baines DL, Howe SJ, Hart SL. Munye MM, et al. Am J Physiol Lung Cell Mol Physiol. 2017 Feb 1;312(2):L258-L267. doi: 10.1152/ajplung.00471.2016. Epub 2016 Dec 15. Am J Physiol Lung Cell Mol Physiol. 2017. PMID: 27979861 Free PMC article.

10

Prospects for RNA delivery with nanotechnologies.

Hart SL. Hart SL. Gene Ther. 2017 Mar;24(3):121. doi: 10.1038/gt.2017.15. Gene Ther. 2017. PMID: 28356601 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,612 results

Search Page